Back to search
Reflux Esophagitis (RE)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Reflux Esophagitis (RE) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Reflux Esophagitis (RE) trials you may qualify forThis Phase III clinical trial is designed to assess the efficacy and safety of Anaprazole 60 mg once daily (QD) administered over a period of up to 8 weeks, com…
To evaluate the efficacy and safety of JP-1366 tablets and Nexium® (Esomeprazole magnesium enteric-coated tablets) in subjects with reflux esophagitis.
The objective of this investigation is to collect following data in patients given NEXIUM capsule (NEXIUM) in usual post-marketing use.
The objective of this study is to assess the safety, pharmacokinetics, pharmacodynamics and efficacy of repeated once daily oral administration of D961H 10 mg a…
The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repe…